Systemic treatment for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common cancers with high mortality worldwide. Treatment options for patients with advanced stage HCC remain a great challenge. However, novel agents especially small molecule tyrosine kinase inhibitor and innovative immunotherapy demonstrate new prom...
Main Authors: | Manushi Aggarwal, Abeer Arain, Zhaohui Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-09-01
|
Series: | Chronic Diseases and Translational Medicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2095882X18300471 |
Similar Items
-
The Evolving Systemic Treatment for Advanced Hepatocellular Carcinoma
by: Sara De Dosso, et al.
Published: (2021-12-01) -
Current hepatocellular carcinoma systemic pharmacological treatment options
by: A. Caturano, et al.
Published: (2023-05-01) -
Advancements in the Treatment Landscape of Hepatocellular Carcinoma
by: Takefumi Kimura
Published: (2024-03-01) -
Abdominal Ultrasound and Treatment of Hepatocellular Carcinoma
by: Kazushi Numata
Published: (2021-07-01) -
Recent Advancements for the Treatment of Hepatocellular Carcinoma
by: Kazuhiro Nouso
Published: (2023-09-01)